Abiopharma

🔍 Maleh Paul A (Executive)

Company: CRA INTERNATIONAL, INC. (CRAI)

Report Date: 2026-06-12

Detailed Transactions and Holdings:

• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-12 | Code: H | shares_owned_after: 111,050.00
• Acquired 26 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-12 | Code: A | equity_swap_involved: 0 | shares_owned_after: 6,825.76 | transaction_form_type: 4 | Footnotes: F1, F2, F2
• Acquired 6 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-12 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,565.17 | transaction_form_type: 4 | Footnotes: F1, F3, F3
• Acquired 10 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-12 | Code: A | equity_swap_involved: 0 | shares_owned_after: 2,747.38 | transaction_form_type: 4 | Footnotes: F1, F4, F4
• Acquired 11 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-12 | Code: A | equity_swap_involved: 0 | shares_owned_after: 2,906.80 | transaction_form_type: 4 | Footnotes: F1, F5, F5
• Acquired 20 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-12 | Code: A | equity_swap_involved: 0 | shares_owned_after: 5,406.25 | transaction_form_type: 4 | Footnotes: F1, F6, F6
• Acquired 13 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-12 | Code: A | equity_swap_involved: 0 | shares_owned_after: 3,345.10 | transaction_form_type: 4 | Footnotes: F1, F7, F7
• Holds 16,304 shares of Nonqualified Stock Option (right to buy) at $44.87 per share (Derivative)
  Date: 2026-06-12 | Code: H | Expires: 2027-12-18 | Exercise: 2017-12-18 | shares_owned_after: 16,304.00 | Footnotes: F8
• Holds 15,173 shares of Nonqualified Stock Option (right to buy) at $47.45 per share (Derivative)
  Date: 2026-06-12 | Code: H | Expires: 2028-12-06 | Exercise: 2018-12-06 | shares_owned_after: 15,173.00 | Footnotes: F8

Footnotes:

• F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock; vested RSUs are payable in the form of cash, shares of the Issuer's common stock or a combination thereof, except as otherwise indicated below. To the extent vested RSUs are paid in shares of the Issuer's common stock, such shares will be delivered to the reporting person as soon as possible after vesting, but in no event later than two and one-half months after the end of the year in which vesting occurs, subject to the collection of withholding taxes. Dividend equivalent rights accrue with respect to unvested RSUs in the form of additional RSUs ("Dividend Units") when and as dividends are paid on the Issuer's common stock, and Dividend Units vest on the same dates and in the same relative proportions as the RSUs on which they accrue.
• F2: The RSUs, which include an aggregate of 25.7592 Dividend Units, vest in four equal annual installments beginning on April 9, 2027.
• F3: The RSUs, which include an aggregate of 61.1652 Dividend Units, vest on April 11, 2027.
• F4: The RSUs, which include an aggregate of 107.3801 Dividend Units, vest on April 11, 2027.
• F5: The RSUs, which include an aggregate of 73.7967 Dividend Units, vest in two equal annual installments beginning on April 29, 2027.
• F6: The RSUs, which include an aggregate of 137.2476 Dividend Units, vest in two equal annual installments beginning on April 29, 2027.
• F7: The RSUs, which include an aggregate of 51.1005 Dividend Units, vest in three equal annual installments beginning on May 20, 2027.
• F8: Date indicated is date of grant. Option vests in four equal annual installments beginning on the first anniversary of the date of grant.